Skip to main content

Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Publication ,  Journal Article
Abu-Rustum, NR; Yashar, CM; Bean, S; Bradley, K; Campos, SM; Chon, HS; Chu, C; Cohn, D; Crispens, MA; Damast, S; Dorigo, O; Eifel, PJ; Han, E ...
Published in: J Natl Compr Canc Netw
November 1, 2019

Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, high-risk GTN, and intermediate trophoblastic tumor.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 1, 2019

Volume

17

Issue

11

Start / End Page

1374 / 1391

Location

United States

Related Subject Headings

  • Pregnancy
  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Gestational Trophoblastic Disease
  • Female
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Abu-Rustum, N. R., Yashar, C. M., Bean, S., Bradley, K., Campos, S. M., Chon, H. S., … Scavone, J. (2019). Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(11), 1374–1391. https://doi.org/10.6004/jnccn.2019.0053
Abu-Rustum, Nadeem R., Catheryn M. Yashar, Sarah Bean, Kristin Bradley, Susana M. Campos, Hye Sook Chon, Christina Chu, et al. “Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 17, no. 11 (November 1, 2019): 1374–91. https://doi.org/10.6004/jnccn.2019.0053.
Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, et al. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 Nov 1;17(11):1374–91.
Abu-Rustum, Nadeem R., et al. “Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, vol. 17, no. 11, Nov. 2019, pp. 1374–91. Pubmed, doi:10.6004/jnccn.2019.0053.
Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Wyse E, McMillian NR, Scavone J. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 Nov 1;17(11):1374–1391.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 1, 2019

Volume

17

Issue

11

Start / End Page

1374 / 1391

Location

United States

Related Subject Headings

  • Pregnancy
  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Gestational Trophoblastic Disease
  • Female
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis